San Diego, USA-based biotech AnaptysBio saw its shares climb by 10.4% to $25.70 in pre-market trading, following its ...

US drugmaker AbbVie has announced plans to launch Elahere (mirvetuximab soravtansine-gynx) in the UK at a list price equal to ...

US biotech Star Therapeutics, which is developing best-in-class antibodies for bleeding disorders and other diseases, today ...

Privately-held French biotech focused on providing immuno-therapeutics Biomunex Pharmaceuticals today announced a capital ...

Shares in Enanta Pharmaceuticals, a US biotech creating small molecule drugs for viral infections and immunological diseases, ...

US obesity firm Metsera has presented new data that demonstrates why pharma giant Pfizer is paying up to $7.3 billion to buy ...

Boston, USA-based biotech Cue Biopharma has announced the appointment of Dr Usman Azam as its new president and chief executive (CEO), supporting the company’s advancement of its first-in-class ...

US eye disease specialist Kala Bio saw its shares close down almost 90% at $2.04 yesterday, after it revealed disappointing ...

President Donald Trump has called on US industries to put America first, and the biopharmaceutical sector is answering that ...

Shares of US clinical-stage biotech Dogwood Therapeutics soared a massive 43% to $7.91 yesterday, on the news it has secured ...

US health technology body ICER will review the comparative clinical effectiveness and value of four COVID-19 vaccines: Pfizer ...

For years, rare diseases were seen as a safe harbor for biotech and pharma: small patient populations, little competition, ...